{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:28:48Z","timestamp":1745580528168},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,18]]},"DOI":"10.7759\/cureus.47248","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T09:20:24Z","timestamp":1697620824000},"source":"Crossref","is-referenced-by-count":1,"title":["Oromandibular Dystonia as a Side Effect of Methotrexate"],"prefix":"10.7759","author":[{"given":"Diana","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Toste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/aian.aian_242_21","article-title":"Oromandibular dystonia - a systematic review","volume":"25","author":"Saraf U","year":"2022","unstructured":"Saraf U, Chandarana M, Divya KP, Krishnan S. Oromandibular dystonia - a systematic review. Ann Indian Acad Neurol. 2022, 25:26-34. 10.4103\/aian.aian_242_21","journal-title":"Ann Indian Acad Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese A","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, et al.. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013, 28:863-73. 10.1002\/mds.25475","journal-title":"Mov Disord"},{"key":"ref3","article-title":"Etiology, diagnosis and management of oromandibular dystonia: an update for stomatologists","volume":"18","author":"Raoofi S","year":"2017","unstructured":"Raoofi S, Khorshidi H, Najafi M. Etiology, diagnosis and management of oromandibular dystonia: an update for stomatologists . J Dent (Shiraz). 2017, 18:73-81.","journal-title":"J Dent (Shiraz)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0972-6748.207853","article-title":"Meige's syndrome","volume":"25","author":"Gautam P","year":"2016","unstructured":"Gautam P, Bhatia MS, Kaur J, Rathi A. Meige's syndrome. Ind Psychiatry J. 2016, 25:232-3. 10.4103\/0972-6748.207853","journal-title":"Ind Psychiatry J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.583177","article-title":"Development and validation of a disease-specific oromandibular dystonia rating scale (OMDRS)","volume":"11","author":"Yoshida K","year":"2020","unstructured":"Yoshida K. Development and validation of a disease-specific oromandibular dystonia rating scale (OMDRS). Front Neurol. 2020, 11:583177. 10.3389\/fneur.2020.583177","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12040269","article-title":"Treatment of blepharospasm and oromandibular dystonia with botulinum toxins","volume":"12","author":"Hassell TJ","year":"2020","unstructured":"Hassell TJ, Charles D. Treatment of blepharospasm and oromandibular dystonia with botulinum toxins. Toxins (Basel). 2020, 12:269. 10.3390\/toxins12040269","journal-title":"Toxins (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2018.02.006","article-title":"Systematic review of botulinum toxin treatment for oromandibular dystonia","volume":"147","author":"Comella CL","year":"2018","unstructured":"Comella CL. Systematic review of botulinum toxin treatment for oromandibular dystonia. Toxicon. 2018, 147:96-9. 10.1016\/j.toxicon.2018.02.006","journal-title":"Toxicon"},{"key":"ref9","article-title":"Oro-bucco-lingual dyskinesia as a side effect of methotrexate therapy","volume":"37","author":"Sarac H","year":"2022","unstructured":"Sarac H, Borovecki F, Sarac I, Henigsberg N. Oro-bucco-lingual dyskinesia as a side effect of methotrexate therapy. Mov Disord. 2022, 37:S250-1.","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3329\/jemc.v8i3.38369","article-title":"Jaw-closing oromandibular dystonia induced by speaking in a patient with systemic sclerosis","volume":"8","author":"Hasan AT","year":"2018","unstructured":"Hasan AT, Abda SJ, Yesmin S, Ahmed S. Jaw-closing oromandibular dystonia induced by speaking in a patient with systemic sclerosis. J Enam Med Coll. 2018, 8:170-3. 10.3329\/jemc.v8i3.38369","journal-title":"J Enam Med Coll"},{"key":"ref11","unstructured":"Methotrexate and tardive dyskinesia - a phase IV clinical study of FDA data. (2023). Accessed. September 24, 2023: https:\/\/www.ehealthme.com\/ds\/methotrexate\/tardive-dyskinesia\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/194351-oromandibular-dystonia-as-a-side-effect-of-methotrexate","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:16Z","timestamp":1707509476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/194351-oromandibular-dystonia-as-a-side-effect-of-methotrexate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.47248","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,18]]}}}